{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:43:47Z","timestamp":1768869827986,"version":"3.49.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Myocardial infarction (MI) is one of the leading causes of death worldwide, and knowing the early warning signs of MI is lifesaving. To expand our knowledge of MI, we analyzed plasma metabolites in MI and non-MI chest pain cases to identify markers for alerting about MI occurrence based on metabolomics. A total of 230 volunteers were recruited, consisting of 146 chest pain patients admitted with suspected MI (85 MIs and 61 non-MI chest pain cases) and 84 control individuals. Non-MI cardiac chest pain cases include unstable angina (UA), myocarditis, valvular heart diseases, etc. The blood samples of all suspected MI cases were collected not longer than 6 h since the onset of chest pain. Gas chromatography\u2013mass spectrometry and liquid chromatography\u2013mass spectrometry were applied to identify and quantify the plasma metabolites. Multivariate statistical analysis was utilized to analyze the data, and principal component analysis showed MI could be clearly distinguished from non-MI chest pain cases (including UA and other cases) in the scores plot of metabolomic data, better than that based on the data constructed with medical history and clinical biochemical parameters. Pathway analysis highlighted an upregulated methionine metabolism and downregulated arginine biosynthesis in MI cases. Receiver operating characteristic curve (ROC) and adjusted odds ratio (OR) were calculated to evaluate potential markers for the diagnosis and prediction ability of MI (MI vs. non-MI cases). Finally, gene expression profiles from the Gene Expression Omnibus (GEO) database were briefly discussed to study differential metabolites' connection with plasma transcriptomics. Deoxyuridine (dU), homoserine, and methionine scored highly in ROC analysis (AUC &amp;gt; 0.91), sensitivity (&amp;gt;80%), and specificity (&amp;gt;94%), and they were correlated to LDH and AST (<jats:italic>p<\/jats:italic> &amp;lt; 0.05). OR values suggested, after adjusting for gender, age, lipid levels, smoking, type II diabetes, and hypertension history, that high levels of dU of positive logOR = 3.01, methionine of logOR = 3.48, and homoserine of logOR = 1.61 and low levels of isopentenyl diphosphate (IDP) of negative logOR = \u22125.15, uracil of logOR = \u22122.38, and arginine of logOR = \u22120.82 were independent risk factors of MI. Our study highlighted that metabolites belonging to pyrimidine, methionine, and arginine metabolism are deeply influenced in MI plasma samples. dU, homoserine, and methionine are potential markers to recognize MI cases from other cardiac chest pain cases after the onset of chest pains. Individuals with high plasma abundance of dU, homoserine, or methionine have increased risk of MI, too.<\/jats:p>","DOI":"10.3389\/fcvm.2021.652746","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T09:30:31Z","timestamp":1619170231000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Plasma Metabolites Alert Patients With Chest Pain to Occurrence of Myocardial Infarction"],"prefix":"10.3389","volume":"8","author":[{"given":"Nan","family":"Aa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengjie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runbing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liansheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunjian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiye","family":"Aa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangqing","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangji","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1056\/NEJMoa1415516","article-title":"Outcomes of anatomical versus functional testing for coronary artery disease","volume":"372","author":"Douglas","year":"2015","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1080\/1354750X.2018.1490969","article-title":"Possible mechanisms behind cardiac troponin elevations","volume":"23","author":"Hammarsten","year":"2018","journal-title":"Biomarkers."},{"key":"B3","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1080\/1354750X.2017.1334154","article-title":"High sensitivity cardiac troponin T in patients not having an acute coronary syndrome: results from the TRAPID-AMI study","volume":"22","author":"Nowak","year":"2017","journal-title":"Biomarkers."},{"key":"B4","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1080\/1354750X.2018.1460763","article-title":"High-sensitivity cardiac troponin T for diagnosis of NSTEMI in the elderly emergency department patient: a clinical cohort study","volume":"23","author":"Riedlinger","year":"2018","journal-title":"Biomarkers."},{"key":"B5","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.cjca.2016.12.013","article-title":"Metabolic modulators in heart disease: Past, present, and future","volume":"33","author":"Lopaschuk","year":"2017","journal-title":"Can J Cardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/nm1202-802","article-title":"Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics","volume":"8","author":"Brindle","year":"2002","journal-title":"Nat Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.1161\/CIRCULATIONAHA.105.569137","article-title":"Metabolomic identification of novel biomarkers of myocardial ischemia","volume":"112","author":"Sabatine","year":"2005","journal-title":"Circulation."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.111.060368","article-title":"Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function","volume":"126","author":"Shah","year":"2012","journal-title":"Circulation."},{"key":"B9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jacc.2008.03.043","article-title":"Application of metabolomics to cardiovascular biomarker and pathway discovery","volume":"52","author":"Lewis","year":"2008","journal-title":"J Am Coll Cardiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.jacc.2016.06.044","article-title":"Comprehensive metabolomic characterization of coronary artery diseases","volume":"68","author":"Fan","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.jacc.2015.02.018","article-title":"Metabolic disturbances identified in plasma are associated with outcomes in patients with heart failure: diagnostic and prognostic value of metabolomics","volume":"65","author":"Cheng","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1161\/CIRCULATIONAHA.113.002500","article-title":"Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study","volume":"129","author":"Stegemann","year":"2014","journal-title":"Circulation."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.031139","article-title":"Functional metabolomics characterizes a key role for N-Acetylneuraminic acid in coronary artery diseases","volume":"137","author":"Zhang","year":"2018","journal-title":"Circulation."},{"key":"B14","doi-asserted-by":"publisher","first-page":"eaay8329","DOI":"10.1126\/scitranslmed.aay8329","article-title":"Elevated plasma beta-hydroxybutyrate predicts adverse outcomes and disease progression in patients with arrhythmogenic cardiomyopathy","volume":"12","author":"Song","year":"2020","journal-title":"Sci Transl Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","article-title":"Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis","volume":"325","author":"Wald","year":"2002","journal-title":"BMJ."},{"key":"B16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10654-017-0333-0","article-title":"Serum metabolites and risk of myocardial infarction and ischemic stroke: a targeted metabolomic approach in two German prospective cohorts","volume":"33","author":"Floegel","year":"2018","journal-title":"Eur J Epidemiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1016\/j.jacc.2009.02.036","article-title":"Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk","volume":"53","author":"Tang","year":"2009","journal-title":"J Am Coll Cardiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/COH.0b013e32833ed742","article-title":"Analysis of biomarker data: logs, odds ratios, and receiver operating characteristic curves","volume":"5","author":"Grund","year":"2010","journal-title":"Curr Opin HIV AIDS."},{"key":"B19","doi-asserted-by":"publisher","first-page":"8086","DOI":"10.1021\/ac051211v","article-title":"Extraction and GC\/MS analysis of the human blood plasma metabolome","volume":"77","author":"A","year":"2005","journal-title":"Anal Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.biopsych.2019.09.027","article-title":"Reduced neuronal cAMP in the nucleus accumbens damages blood-brain barrier integrity and promotes stress vulnerability","volume":"87","author":"Zhang","year":"2020","journal-title":"Biol Psychiatry."},{"key":"B21","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s11306-019-1577-3","article-title":"Compound danshen dripping pills normalize a reprogrammed metabolism of myocardial ischemia rats to interpret its time-dependent efficacy in clinic trials: a metabolomic study","volume":"15","author":"Aa","year":"2019","journal-title":"Metabolomics."},{"key":"B22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1365-2141.1978.tb01038.x","article-title":"The lymphocyte as a marker of past nutritional status: persistence of abnormal lymphocyte deoxyuridine (dU) suppression test and chromosomes in patients with past deficiency of folate and vitamin B12","volume":"38","author":"Das","year":"1978","journal-title":"Br J Haematol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/0268-960X(88)90022-7","article-title":"Deoxyuridine suppression: biochemical basis and diagnostic applications","volume":"2","author":"Wickramasinghe","year":"1988","journal-title":"Blood Rev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.3390\/jcm8081096","article-title":"Erythrocyte encapsulated thymidine phosphorylase for the treatment of patients with mitochondrial neurogastrointestinal encephalomyopathy: study protocol for a multi-centre, multiple dose, open label trial","volume":"8","author":"Bax","year":"2019","journal-title":"J Clin Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0006-291X(03)00294-8","article-title":"Elevated plasma deoxyuridine in patients with thymidine phosphorylase deficiency","volume":"303","author":"Marti","year":"2003","journal-title":"Biochem Biophys Res Commun."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1002\/ijc.32218","article-title":"Prospective serum metabolomic profiling of lethal prostate cancer","volume":"145","author":"Huang","year":"2019","journal-title":"Int J Cancer."},{"key":"B27","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1210\/me.2009-0152","article-title":"Early hepatic insulin resistance in mice: a metabolomics analysis","volume":"24","author":"Li","year":"2010","journal-title":"Mol Endocrinol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1253\/circj.CJ-11-0622","article-title":"Identification of biomarkers of stent restenosis with serum metabolomic profiling using gas chromatography\/mass spectrometry","volume":"76","author":"Hasokawa","year":"2012","journal-title":"Circ J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"15089","DOI":"10.1073\/pnas.2436385100","article-title":"The atherogenic effect of excess methionine intake","volume":"100","author":"Troen","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"B30","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/S0735-1097(85)80473-3","article-title":"Methionine intolerance: a possible risk factor for coronary artery disease","volume":"6","author":"Murphy-Chutorian","year":"1985","journal-title":"J Am Coll Cardiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/CIRCGENETICS.109.852814","article-title":"Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events","volume":"3","author":"Shah","year":"2010","journal-title":"Circ Cardiovasc Genet."},{"key":"B32","doi-asserted-by":"publisher","first-page":"8935","DOI":"10.1038\/sj.onc.1205996","article-title":"Uracil in DNA\u2013occurrence, consequences and repair","volume":"21","author":"Krokan","year":"2002","journal-title":"Oncogene."},{"key":"B33","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/cvr\/cvaa101","article-title":"Single cell RNA sequencing reveals profound changes in circulating immune cells in patients with heart failure","volume":"117","author":"Abplanalp","year":"2020","journal-title":"Cardiovasc Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.06.019","article-title":"Lymphocyte-to-monocyte ratio: a novel predictor of the prognosis of acute ischemic stroke","volume":"26","author":"Ren","year":"2017","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/s41467-018-03961-y","article-title":"Non-invasive detection of human cardiomyocyte death using methylation patterns of circulating DNA","volume":"9","author":"Zemmour","year":"2018","journal-title":"Nat Commun"},{"key":"B36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4137\/CMC.S10225","article-title":"Unique and varied contributions of traditional CVD risk factors: a systematic literature review of CAD risk factors in China","volume":"7","author":"Foody","year":"2013","journal-title":"Clin Med Insights Cardiol."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.652746\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T09:30:37Z","timestamp":1619170237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.652746\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,23]]},"references-count":36,"alternative-id":["10.3389\/fcvm.2021.652746"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.652746","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,23]]},"article-number":"652746"}}